We are live on ! Find out more
DCM

DME Capital Management Portfolio holdings

AUM $3.19B
1-Year Est. Return 23.22%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+23.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.85B
AUM Growth
+$308M
Cap. Flow
+$334M
Cap. Flow %
11.71%
Top 10 Hldgs %
65.06%
Holding
45
New
8
Increased
11
Reduced
12
Closed
4

Top Buys

Rank Stock Value
1
GPK icon
Graphic Packaging
GPK
+$61M
2
CPRI icon
Capri Holdings
CPRI
+$48.1M
3
ACHC icon
Acadia Healthcare
ACHC
+$46.9M
4
CNC icon
Centene
CNC
+$40.4M
5
SPB icon
Spectrum Brands
SPB
+$37.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 37.66%
2 Healthcare 14.27%
3 Energy 14.18%
4 Industrials 10.82%
5 Financials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRBK icon
1
Green Brick Partners
GRBK
$3.12B
$593M 20.82%
9,467,383
FLR icon
2
Fluor
FLR
$7.22B
$220M 7.73%
5,555,900
+42,220
+0.8% +$1.87M
CNR
3
Core Natural Resources Inc
CNR
$4.16B
$186M 6.52%
2,100,480
-55,160
-3% -$4.7M
BHF icon
4
Brighthouse Financial
BHF
$3.63B
$181M 6.35%
2,792,100
GPK icon
5
Graphic Packaging
GPK
$3.3B
$127M 4.45%
8,415,110
+3,709,160
+79% +$61M
PCG icon
6
PG&E
PCG
$47.2B
$125M 4.39%
7,784,103
+1,403,250
+22% +$22.4M
CPRI icon
7
Capri Holdings
CPRI
$1.82B
$116M 4.08%
4,768,007
+2,080,410
+77% +$48.1M
CNC icon
8
Centene
CNC
$31.6B
$109M 3.81%
2,639,420
+1,078,880
+69% +$40.4M
KD icon
9
Kyndryl
KD
$2.81B
$101M 3.56%
3,816,353
-527,274
-12% -$14.3M
TEVA icon
10
Teva Pharmaceuticals
TEVA
$36.2B
$95.5M 3.35%
3,058,734
-720,043
-19% -$17.7M
VSXY
11
Victoria's Secret
VSXY
$6.78B
$94.1M 3.3%
1,737,869
-194,593
-10% -$7.73M
DHT icon
12
DHT Holdings
DHT
$2.95B
$89.9M 3.16%
7,366,664
-254,270
-3% -$3.2M
PENN icon
13
PENN Entertainment
PENN
$2.83B
$89.2M 3.13%
6,044,440
-725,000
-11% -$11.3M
GLD icon
14
SPDR Gold Trust
GLD
$132B
$67.6M 2.37%
170,561
-4,540
-3% -$1.73M
ACHC icon
15
Acadia Healthcare
ACHC
$2.99B
$58.5M 2.05%
4,121,203
+2,478,493
+151% +$46.9M
WFRD icon
16
Weatherford International
WFRD
$6.16B
$58.2M 2.04%
743,620
-217,190
-23% -$15.8M
LBTYA icon
17
Liberty Global Class A
LBTYA
$3.35B
$55.7M 1.96%
5,004,432
-216,070
-4% -$2.39M
CNH
18
CNH Industrial
CNH
$13.7B
$53.2M 1.87%
5,767,540
-136,920
-2% -$1.37M
ROIV icon
19
Roivant Sciences
ROIV
$25B
$44.9M 1.58%
2,069,309
-206,220
-9% -$4.07M
WBD icon
20
Warner Bros
WBD
$63.4B
$44.2M 1.55%
+1,533,080
New +$35.8M
SPB icon
21
Spectrum Brands
SPB
$2.04B
$39.2M 1.38%
+663,890
New +$37.3M
HSIC icon
22
Henry Schein
HSIC
$9.64B
$35.5M 1.24%
+469,250
New +$33M
GPN icon
23
Global Payments
GPN
$23B
$35M 1.23%
+452,730
New +$36.4M
BKV
24
BKV Corp
BKV
$2.71B
$35M 1.23%
+1,287,943
New +$32.3M
AR icon
25
Antero Resources
AR
$10.5B
$34.9M 1.23%
+1,014,070
New +$34.3M

Similar funds

DME Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, DME Capital Management held 45 positions worth $2.85B, up 12% from $2.54B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

DME Capital Management deployed $334M of net new capital in Q4 2025, opening 8 new positions and adding to 11 existing holdings. Its largest new stake was Spectrum Brands: 663,890 shares worth $39.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 38% of assets, down from 41% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $17.7M trimmed.

  • DME Capital Management's largest Q4 2025 buy was Spectrum Brands: 663,890 shares worth $39.2M.
  • DME Capital Management added most to Graphic Packaging in Q4 2025, an estimated $61M increase.
  • DME Capital Management's biggest Q4 2025 reduction was Teva Pharmaceuticals, cutting an estimated $17.7M.
  • DME Capital Management fully exited Seadrill in Q4 2025, selling an estimated $48M.
  • DME Capital Management's ten largest holdings make up 65% of its $2.85B portfolio in Q4 2025.
  • DME Capital Management opened 8 new positions and closed 4 in Q4 2025.
  • DME Capital Management's portfolio value rose 12% quarter-over-quarter to $2.85B.

Based on DME Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.